Ewa Surmiak

497 total citations
22 papers, 375 citations indexed

About

Ewa Surmiak is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Ewa Surmiak has authored 22 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 7 papers in Organic Chemistry. Recurrent topics in Ewa Surmiak's work include Cancer-related Molecular Pathways (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Click Chemistry and Applications (5 papers). Ewa Surmiak is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Click Chemistry and Applications (5 papers). Ewa Surmiak collaborates with scholars based in Poland, Netherlands and Germany. Ewa Surmiak's co-authors include Tad A. Holak, Łukasz Skalniak, Alexander Dömlingꝉ, Bogdan Musielak, Jacek Plewka, Justyna Kocik-Krol, Katarzyna Magiera‐Mularz, Radosław Kitel, Constantinos G. Neochoritis and Aleksandra Twarda‐Clapa and has published in prestigious journals such as Angewandte Chemie International Edition, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Ewa Surmiak

21 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewa Surmiak Poland 11 205 191 126 34 34 22 375
Bizhu Chu China 14 293 1.4× 96 0.5× 131 1.0× 19 0.6× 22 0.6× 31 460
Carlo Baggio United States 14 336 1.6× 143 0.7× 235 1.9× 35 1.0× 60 1.8× 28 539
Christopher E. Whitehead United States 10 291 1.4× 112 0.6× 77 0.6× 42 1.2× 27 0.8× 25 461
Andrew B. Benowitz United States 13 509 2.5× 207 1.1× 187 1.5× 26 0.8× 19 0.6× 22 714
Marie Suggitt United Kingdom 8 201 1.0× 147 0.8× 116 0.9× 26 0.8× 28 0.8× 9 435
John P. Wolak United States 7 149 0.7× 86 0.5× 115 0.9× 45 1.3× 31 0.9× 7 294
Keiko Tsuganezawa Japan 12 209 1.0× 66 0.3× 111 0.9× 29 0.9× 36 1.1× 20 328
Diane Maguire United States 6 175 0.9× 125 0.7× 168 1.3× 29 0.9× 31 0.9× 6 360
Parima Udompholkul United States 12 275 1.3× 122 0.6× 218 1.7× 26 0.8× 52 1.5× 19 427
Henrik Moebitz Switzerland 5 325 1.6× 119 0.6× 105 0.8× 58 1.7× 13 0.4× 8 441

Countries citing papers authored by Ewa Surmiak

Since Specialization
Citations

This map shows the geographic impact of Ewa Surmiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Surmiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Surmiak more than expected).

Fields of papers citing papers by Ewa Surmiak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Surmiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Surmiak. The network helps show where Ewa Surmiak may publish in the future.

Co-authorship network of co-authors of Ewa Surmiak

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Surmiak. A scholar is included among the top collaborators of Ewa Surmiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Surmiak. Ewa Surmiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Musielak, Bogdan, Alexander Dömlingꝉ, Tad A. Holak, et al.. (2024). C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein–Protein Interaction. Molecules. 29(11). 2646–2646. 1 indexed citations
2.
Surmiak, Ewa, Roberto Butera, Katarzyna Magiera‐Mularz, et al.. (2024). 1,5-Disubstituted tetrazoles as PD-1/PD-L1 antagonists. RSC Medicinal Chemistry. 15(4). 1210–1215. 1 indexed citations
3.
Kitel, Radosław, Ewa Surmiak, Jan Borggräfe, et al.. (2023). Discovery of Inhibitory Fragments That Selectively Target Spire2–FMN2 Interaction. Journal of Medicinal Chemistry. 66(23). 15715–15727.
4.
Surmiak, Ewa, Jacek Plewka, Justyna Kocik-Krol, et al.. (2023). Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for m-Terphenyl Derivatives. ACS Medicinal Chemistry Letters. 15(1). 36–44. 7 indexed citations
5.
Rubner, Stefan, Przemysław Golik, Ewa Surmiak, et al.. (2023). Nutlin‐3a‐aa: Improving the Bioactivity of a p53/MDM2 Interaction Inhibitor by Introducing a Solvent‐Exposed Methylene Group. ChemBioChem. 24(6). e202300006–e202300006. 5 indexed citations
6.
Kitel, Radosław, Ewa Surmiak, Katarzyna Magiera‐Mularz, et al.. (2022). Exploring the Surface of the Ectodomain of the PD-L1 Immune Checkpoint with Small-Molecule Fragments. ACS Chemical Biology. 17(9). 2655–2663. 12 indexed citations
7.
Shaabani, Shabnam, Ewa Surmiak, Roberto Butera, et al.. (2022). Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. Molecules. 27(11). 3454–3454. 5 indexed citations
8.
Surmiak, Ewa, Jacek Plewka, Katarzyna Magiera‐Mularz, et al.. (2021). Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein–Protein Interaction. Journal of Medicinal Chemistry. 64(15). 11614–11636. 61 indexed citations
9.
Surmiak, Ewa, Katarzyna Magiera‐Mularz, Bogdan Musielak, et al.. (2021). PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action. International Journal of Molecular Sciences. 22(21). 11797–11797. 27 indexed citations
10.
Butera, Roberto, Katarzyna Magiera‐Mularz, Jacek Plewka, et al.. (2021). Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists. ACS Medicinal Chemistry Letters. 12(5). 768–773. 44 indexed citations
11.
Ricardo, Manuel G., Jacek Plewka, Ewa Surmiak, et al.. (2020). Multicomponent Peptide Stapling as a Diversity‐Driven Tool for the Development of Inhibitors of Protein–Protein Interactions. Angewandte Chemie. 132(13). 5273–5279. 6 indexed citations
12.
Neochoritis, Constantinos G., Aleksandra Twarda‐Clapa, Ewa Surmiak, et al.. (2019). Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction. European Journal of Medicinal Chemistry. 182. 111588–111588. 9 indexed citations
13.
Brela, Mateusz Z., et al.. (2019). The synthesis and characterization of tetramic acid derivatives as Mdm2-p53 inhibitors. Journal of Molecular Structure. 1189. 161–174. 2 indexed citations
14.
Skalniak, Łukasz, Ewa Surmiak, & Tad A. Holak. (2019). A therapeutic patent overview of MDM2/X-targeted therapies (2014–2018). Expert Opinion on Therapeutic Patents. 29(3). 151–170. 32 indexed citations
15.
Neochoritis, Constantinos G., Eman M. M. Abdelraheem, Ewa Surmiak, et al.. (2019). Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists. Beilstein Journal of Organic Chemistry. 15. 513–520. 11 indexed citations
16.
Skalniak, Łukasz, Aleksandra Twarda‐Clapa, Constantinos G. Neochoritis, et al.. (2019). A fluorinated indole‐based MDM2 antagonist selectively inhibits the growth of p53wt osteosarcoma cells. FEBS Journal. 286(7). 1360–1374. 10 indexed citations
17.
Brela, Mateusz Z., et al.. (2019). Comparison of the Hydrogen Bond Interaction Dynamics in the Guanine and Cytosine Crystals: Ab Initio Molecular Dynamics and Spectroscopic Study. The Journal of Physical Chemistry A. 123(50). 10757–10763. 6 indexed citations
18.
Surmiak, Ewa, Marcin D. Tomala, Aleksandra Twarda‐Clapa, et al.. (2018). NMR fragment-based screening for development of the CD44-binding small molecules. Bioorganic Chemistry. 82. 284–289. 4 indexed citations
19.
Surmiak, Ewa, Constantinos G. Neochoritis, Bogdan Musielak, et al.. (2016). Rational design and synthesis of 1,5-disubstituted tetrazoles as potent inhibitors of the MDM2-p53 interaction. European Journal of Medicinal Chemistry. 126. 384–407. 29 indexed citations
20.
Surmiak, Ewa, Aleksandra Twarda‐Clapa, Krzysztof M. Żak, et al.. (2016). A Unique Mdm2-Binding Mode of the 3-Pyrrolin-2-one- and 2-Furanone-Based Antagonists of the p53-Mdm2 Interaction. ACS Chemical Biology. 11(12). 3310–3318. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bizhu Chu Breakdown of academic impact, for papers by Carlo Baggio Breakdown of academic impact, for papers by Christopher E. Whitehead Breakdown of academic impact, for papers by Andrew B. Benowitz Breakdown of academic impact, for papers by Marie Suggitt Breakdown of academic impact, for papers by John P. Wolak Breakdown of academic impact, for papers by Keiko Tsuganezawa Breakdown of academic impact, for papers by Diane Maguire Breakdown of academic impact, for papers by Parima Udompholkul Breakdown of academic impact, for papers by Henrik Moebitz
Rankless by CCL
2026